Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. (SZSE:301075) for CNY 0 on January 19, 2024. As of September 30, 2023, in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. generated total assets of CNY 3.1 million and net assets of CNY 3.1 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 CNY | +6.19% | -11.75% | -38.88% |
1st Jan change | Capi. | |
---|---|---|
-38.88% | 18Cr | |
+45.82% | 77TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.75% | 25TCr | |
-1.39% | 22TCr | |
+10.96% | 22TCr | |
+5.90% | 16TCr | |
-0.73% | 16TCr |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Jiangxi Kelun Pharmaceutical Co., Ltd. and Hubei Yinuokang Medical Technology Co., Ltd. agreed to acquire 49% stake in Wuhan Quanruinuo Pharmaceutical Technology Co., Ltd. from Tibet Duo Rui Pharmaceutical Co.,Ltd. for CNY 0.